Expert Scientific Advisory Committee (ESAC)
MMV’s Expert Scientific Advisory Committee (ESAC) helps to identify the best projects worthy of inclusion in the portfolio and continues to monitor progress through an annual review of all projects. This committee consists of experts from both industry and academia and covers the full range of expertise required to assess projects that are engaging in the extremely complex process of drug research and development.
ESAC Members
Dr Jane Achan, Senior Research Advisor, Malaria Consortium. United Kingdom/Uganda
Dr Kevin Beaumont, Oncology R&D with DMPK expertise, AstraZeneca. UK
Dr Delese Mimi Darko, Chief Executive Officer, Safety Monitoring & Clinical Trials Division, Food and Drugs Authority. Ghana
Dr Natalie Hawryluk, Executive Director of Drug Discovery and Early Development, Edgewise Therapeutics. USA
Dr Jacqueline Kinyamu Akunda, Senior Scientific Director, Oncology, Janssen Pharmaceuticals. USA
Dr Dave Lathbury, former Director of Process Chemistry, AstraZeneca. UK
Dr Mary Mader, Co-Chair MMV ESAC (Discovery), Vice President of Molecular Innovation at the Indiana Biosciences Research Institute (IBRI). USA
Dr Iain Martin, Senior Vice President of Nonclinical Development at Relay Therapeutics. UK
Dr Lynn Marks, Co-Chair MMV ESAC (Development), former Senior Vice President GlaxoSmithKline R&DUSA
Dr Jane Stewart, Reproductive Toxicology Associate, ApconiX. UK
Dr Halidou Tinto, Regional Director Institut de Recherche en Sciences de la Santé (IRSS). Burkina Faso
Dr Elizabeth Vadas, Former Executive Director Merck Frosst and Merck & Co; Consultant InSciTech Inc., Canada
Dr Neena Valecha, former Regional Adviser, Malaria at the World Health Organization (WHO). India
Prof Simon Ward, Sêr Cymru Professor in Translational Drug Discovery and Director of the Medicines Institute at Cardiff University, UK
Prof Stephen Ward, Deputy Director and Walter Myers Professor of Parasitology at Liverpool School of Tropical Medicine (LSTM), UK
Prof Dyann Wirth, Director, Harvard Malaria Initiative, Harvard School of Public Health, USA